(Q46230582)

20 December 2017

title

The effect of marine n-3 fatty acids in different doses on plasma concentrations of Lp-PLA2 in healthy adults (English)

1 reference

20 December 2017

author

Erik B Schmidt

4

1 reference

20 December 2017

author name string

Maria Weinkouff Pedersen

1

1 reference

20 December 2017

Wolfgang Koenig

2

1 reference

20 December 2017

Jeppe Hagstrup Christensen

3

1 reference

20 December 2017

publication date

21 November 2008

1 reference

20 December 2017

European Journal of Nutrition

published in

1 reference

20 December 2017

volume

48

1 reference

20 December 2017

issue

1

1 reference

20 December 2017

page(s)

1-5

1 reference

20 December 2017

Heart rate variability and fatty acid content of blood cell membranes: a dose-response study with n-3 fatty acids

cites work

1 reference

12 December 2020

A few more thoughts about fish and fish oil

1 reference

12 December 2020

Polyunsaturated fatty acids and inflammation

1 reference

12 December 2020

The epidemiology of Lp-PLA(2): distribution and correlation with cardiovascular risk factors in a population-based cohort

1 reference

12 December 2020

Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group

1 reference

12 December 2020

Role of lipoprotein-associated phospholipase A2 in leukocyte activation and inflammatory responses

1 reference

12 December 2020

PLAC test for identification of individuals at increased risk for coronary heart disease.

1 reference

12 December 2020

Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review

1 reference

12 December 2020

Lipoprotein-associated phospholipase A2 does not predict mortality or new ischaemic events in acute coronary syndrome patients

1 reference

12 December 2020

Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study

1 reference

12 December 2020

The effect of dietary n-3 fatty acids on serum concentrations of C-reactive protein: a dose-response study

1 reference

12 December 2020

Lipoprotein-associated phospholipase A2 (platelet-activating factor acetylhydrolase) and cardiovascular disease

1 reference

12 December 2020

Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study

1 reference

12 December 2020

Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern G

1 reference

12 December 2020

Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention

1 reference

12 December 2020

A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in women

1 reference

12 December 2020

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease

1 reference

12 December 2020

Marine n-3 polyunsaturated fatty acids and coronary heart disease. Part I. Background, epidemiology, animal data, effects on risk factors and safety

1 reference

12 December 2020

Lipoprotein-associated phospholipase A2 concentrations in plasma are associated with the extent of coronary artery disease and correlate to adipose tissue levels of marine n-3 fatty acids

1 reference

12 December 2020

Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque

1 reference

12 December 2020

Elevated Lp-PLA 2 Levels Add Prognostic Information to the Metabolic Syndrome on Incidence of Cardiovascular Events Among Middle-Aged Nondiabetic Subjects

1 reference

12 December 2020

Marine n-3 polyunsaturated fatty acids and coronary heart disease: Part II. clinical trials and recommendations

1 reference

12 December 2020

Potent, orally active inhibitors of lipoprotein-associated phospholipase A(2): 1-(biphenylmethylamidoalkyl)-pyrimidones

1 reference

12 December 2020

An evolving story of lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular risk prediction

1 reference

12 December 2020

Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis

1 reference

12 December 2020

Lipoprotein-associated phospholipase A2 and prognosis after myocardial infarction in the community

1 reference

12 December 2020

Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies

1 reference

12 December 2020

Identifying the vulnerable patient with rupture-prone plaque

1 reference

12 December 2020

Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up

1 reference

12 December 2020

The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndrome

1 reference

12 December 2020

Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial

1 reference

12 December 2020

Fish consumption and incidence of stroke: a meta-analysis of cohort studies

1 reference

12 December 2020

n-3 fatty acids and leukocyte chemotaxis. Effects in hyperlipidemia and dose-response studies in healthy men.

1 reference

12 December 2020

10.1007/S00394-008-0758-Z

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017